In a nutshell This study compared survival rates for two surgical strategies in treating invasive breast cancer. The main finding was that the targeted Sentinel Lymph Node Dissection (SLND) procedure was just as effective as the traditional Axillary Lymph Node Dissection (ALND) surgery. Some background Lymph from the breast drains...
Read MorePerformance status-2 – Symptomatic, 50 in bed Posts on Medivizor
Oxaliplatin improves survival in different groups of patients with stage III colon cancer.
In a nutshell The present article compared survival rates of adjuvant chemotherapy regimens with and without Oxaliplatin in patients with stage III colon cancer. This article shows that Oxaliplatin improved survival in large clinical trials. Some background Treatment for patients with stage III colon cancer consists of surgery to...
Read MoreComparing the benefits of two drug combinations as adjuvant chemotherapy for patients with stage III colon cancer
In a nutshell The present study compared the survival benefits of two drug combinations used for adjuvant chemotherapy: Capecitabine/Oxaliplatin (Xelox) versus Fluorouracil/Folinic Acid (FU/FA). The study found Xelox to be a superior therapy for stage III colon cancer. Some background Stage III colon cancer is cancer...
Read MoreWhat is the preferred duration of post-operative chemotherapy for stage II and III colorectal cancer?
Colorectal cancer (CRC) is one of the main causes of cancer related deaths. Patients diagnosed with CRC are treated with surgery to remove the tumor and affected tissue. If the tumor affects the entire thickness of the colon or rectal wall it is referred to as being stage II; if the local lymph nodes are also affected the cancer is referred to as being a...
Read MoreThe use of systemic chemotherapy for patients with poorly differentiated and signet cell adenocarcinoma of the appendix
In a nutshell The present study evaluated the effects of systemic chemotherapy and cytoreductive surgery (CRS) on survival in patients with aggressive types of cancer of the appendix (poorly differentiated and signet ring cell adenocarcinoma). The main findings were that systemic chemotherapy appears to be a viable treatment option for these types of...
Read More